Table 2.
Mortality within 100 days after transplant.
| Patient | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
| Age (years) | 50 | 46 | 47 | 24 | 41 |
| Gender | M | F | F | M | M |
| Disease | Follicular | Lymphocytic | Follicular | CLL | Follicular |
| Time from diagnosis to transplant (months) | 25 | 186 | 16 | 28 | 14 |
| Conditioning | CyMel | CyMel | FluTBI | CyTBI | FluTBI |
| Disease status | Refractory | Refractory | Refractory | Refractory | Refractory |
| Infection | VRE, candidemia | none | none | Fusarium | Pseudomonas |
| Days to death after transplant | 32 | 33 | 24 | 53 | 81 |
| Cause of death | Gastrointestinal bleeding, sepsis | Lung bleeding | VOD | Sepsis | perforated acute abdomen caused by necrosis of the tumor |
M: male; F: female; CyMel: cytarabine and melphalan; FluTBI: fludarabine and total body irradiation; CLL: chronic lymphocytic leukemia; VRE: vancomycin-resistant enterococci; VOD: venous oclusive disease.